These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 9272603)

  • 1. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 2. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    André P
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
    Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on systemic management of diabetes.
    Masharani U; Rushakoff RJ
    Int Ophthalmol Clin; 2009; 49(2):13-33. PubMed ID: 19349784
    [No Abstract]   [Full Text] [Related]  

  • 5. Poor glycaemic control and retinopathy in non-insulin-dependent diabetes mellitus.
    Bastyr EJ; Janes J; Barnett AH
    Diabet Med; 1997 Nov; 14(11):993-4. PubMed ID: 9400930
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
    Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mealtime glucose regulation in type 2 diabetes.
    Tuomilehto J; Del Prato S
    Int J Clin Pract; 2001; 55(6):380-3. PubMed ID: 11501227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycaemic control in type 2 diabetes.
    Campbell A
    Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
    [No Abstract]   [Full Text] [Related]  

  • 9. A 48-year-old man with uncontrolled diabetes.
    Hu M; Isaacson JH
    Cleve Clin J Med; 2009 Jul; 76(7):413-6. PubMed ID: 19570974
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up.
    Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    Diabetes Res Clin Pract; 2010 Sep; 89(3):296-302. PubMed ID: 20416966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood antioxidant parameters in patients with diabetic retinopathy.
    Siemianowicz K; Gminski J; Telega A; Wójcik A; Posielezna B; Grabowska-Bochenek R; Francuz T
    Int J Mol Med; 2004 Sep; 14(3):433-7. PubMed ID: 15289896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnosis of insulin- and noninsulin-dependent diabetes mellitus--are there therapeutic implications?].
    Tappy L; Fröhlich FE
    Praxis (Bern 1994); 1994 Dec; 83(50):1406-9. PubMed ID: 7801016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to hypoglycaemic valleys.
    Amiel SA
    Int J Clin Pract Suppl; 2002 Jul; (129):3-4. PubMed ID: 12166603
    [No Abstract]   [Full Text] [Related]  

  • 15. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D; Sharma SK; Almustafa M; Jang HC; Azar ST; Danciulescu R; Shestakova M; Ayad NM; Guler S; Bech OM;
    Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
    Campbell IW
    Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive insulin treatment after acute myocardial infarction in diabetes mellitus. Evidence exists from study of non-insulin dependent diabetes in Japan.
    Williams R
    BMJ; 1997 Aug; 315(7107):544. PubMed ID: 9329313
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.